These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19679001)

  • 1. Ribosome-component immune modulation of respiratory tract infections in adults.
    Olivieri D; Chiesa S; Tzani P; Marino P; Robberto E; Marcassa S
    Allergy Asthma Proc; 2009; 30 Suppl 1():S13-9. PubMed ID: 19679001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribosome-component immune modulation of respiratory tract infections in children.
    Fiocchi A; Terracciano L; Martelli A; Bernardo L; Calcinai E; Marcassa S
    Allergy Asthma Proc; 2009; 30 Suppl 1():S21-31. PubMed ID: 19679002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of ribosome-component immune modulator in adults and children.
    Olivieri D; Fiocchi A; Pregliasco F; Veehof S; Cantoni V
    Allergy Asthma Proc; 2009; 30 Suppl 1():S33-6. PubMed ID: 19679003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of ribosome-component immune modulator for preventing recurrent respiratory infections in socialized children.
    Fiocchi A; Omboni S; Mora R; Macchi A; Nespoli L; Arrigoni S; Guastini L; Castelnuovo P; Graziani D; Marcassa S
    Allergy Asthma Proc; 2012; 33(2):197-204. PubMed ID: 22525398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial vaccines and the innate immune system: a journey of rediscovery for the allergist-immunologist and all health care providers.
    Bellanti JA; Settipane RA
    Allergy Asthma Proc; 2009; 30 Suppl 1():S3-4. PubMed ID: 19678999
    [No Abstract]   [Full Text] [Related]  

  • 6. Rationale for the clinical use of a ribosome-component immune modulator.
    Pregliasco F; Terracciano L; Marcassa S; Zava D; Anselmi G
    Allergy Asthma Proc; 2009; 30 Suppl 1():S5-12. PubMed ID: 19679000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effective analysis of ribosome-component immune modulation.
    Fiocchi A; Olivieri D; Marcassa S; Zava D; Robberto E
    Allergy Asthma Proc; 2009; 30 Suppl 1():S37-9. PubMed ID: 19679004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribosomal immunostimulation: assessment of studies evaluating its clinical relevance in the prevention of upper and lower respiratory tract infections in children and adults.
    Bellanti J; Olivieri D; Serrano E
    BioDrugs; 2003; 17(5):355-67. PubMed ID: 14498765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ribomunyl((r)) in the prevention of recurrent respiratory tract infections in adults : overview of clinical results.
    Bousquet J; Oliveri D
    Treat Respir Med; 2006; 5(5):317-24. PubMed ID: 16928145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunovac-VP-4 for prevention of acute respiratory diseases in children's communities].
    Egorova NB; Kurbatova EA; Gruber IM; Semenova IB
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (6):35-40. PubMed ID: 21381375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of recurrent respiratory tract infections in children using a ribosomal immunotherapeutic agent: a clinical review.
    Bousquet J; Fiocchi A
    Paediatr Drugs; 2006; 8(4):235-43. PubMed ID: 16898854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ribosome-component immune modulator for preventing recurring respiratory infections in socialized children.
    Bergamini M; Simeone G; Verga MC; Fiocchi A; Omboni S
    Allergy Asthma Proc; 2013; 34(1):108-9. PubMed ID: 23406944
    [No Abstract]   [Full Text] [Related]  

  • 13. Ribosomal immunotherapy for recurrent respiratory tract infections in children.
    Béné MC; Faure GC
    Paediatr Drugs; 2003; 5(4):223-8. PubMed ID: 12662118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D and respiratory infections.
    de Sa Del Fiol F; Barberato-Filho S; Lopes LC; de Cassia Bergamaschi C
    J Infect Dev Ctries; 2015 Apr; 9(4):355-61. PubMed ID: 25881523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis.
    Cazzola M; Anapurapu S; Page CP
    Pulm Pharmacol Ther; 2012 Feb; 25(1):62-8. PubMed ID: 22155205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non specific immunomodulation in respiratory infections.
    Palma-Carlos AG; Palma-Carlos ML
    Allerg Immunol (Paris); 1990 May; 22(5):179, 181-5. PubMed ID: 2375827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and immunological effects of local vaccination with inactivated bacterial antigens in children with antibody deficiency of the respiratory mucosa].
    Wiersbitzky S; Ballke EH; Bruns R; Dierschke R
    Arztl Jugendkd; 1981; 72(1):1-7. PubMed ID: 6762074
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of various forms of ribomunyl in recurrent respiratory tract infections].
    Girard JP; Gumowski PI; Chavaz A; Lech B
    Schweiz Med Wochenschr; 1988 Jun; 118(22):856-61. PubMed ID: 3291110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulants and prevention of recurrent respiratory tract infections.
    Esposito S; Musio A
    J Biol Regul Homeost Agents; 2013; 27(3):627-36. PubMed ID: 24152832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.